NCT05850273View on ClinicalTrials.gov

Mechanism of Action of Interferon in the Treatment of Myeloproliferative Neoplasms

RecruitingOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

March 16, 2023

Primary Completion Date

March 16, 2028

Study Completion Date

March 16, 2033

Conditions

Myeloproliferative Neoplasm

Trial Locations (1)

94805

RECRUITING

Inserm U1287, Villejuif

All Listed Sponsors

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV